Form 4 for DGX Quest Diagnostics
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001022079-25-000089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-05 | 2025-03-03+ | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F - Tax | $173.74 | -2,871 | 10.6K | -21% | -$498.8K |
| 2025-03-05 | 2025-03-04 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - Grant | $173.74 | +4,434 | 15.0K | +42% | +$770.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-04 | F | D | 1,879 | $173.74 | 13,119 | D | — | — | (F3) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. (F4) The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. |
| 2 | Common | Common Stock | 2025-03-04 | A | A | 4,434 | $173.74 | 14,998 | D | — | — | (F2) Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). |
| 3 | Common | Common Stock | 2025-03-03 | F | D | 992 | $173.74 | 10,564 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |